Thank You!

You have successfully subscribed to the newsletter

Sign up to the newsletter

Sign up to our free newsletters and get the latest news from us delivered to your inbox.

The following is a snapshot of our most recent transactions

ad2-1

MannKind Corporation

Common Stock At-the-Market Offering

$50.0 million

Co-Agent, March 2014

ad2-2

CAPSTEAD

Common Stock At-the-Market Offering

$24.21 million

Sole Agent, November 2013

ad2-3

Ligand

Common Stock At-the-Market Offering

$24.0 million

Co-Agent, October 2013

ad2-4

Vical

Common Stock At-the-Market Offering

$25.0 million

Sole Agent, April 2014

ad2-5

Signpath Pharma

Convertible Preferred Stock & Warrant Multiple Rounds

$13.5 million

Placement Agent, June 2016

ad2-6

STEM CELLS

Common Stock Confidentially Marketed Public Offering

$25.0 million

Financial Advisor, April 2015

ad2-7

MicroVision

Common Stock At-the-Market Offering

$6.0 million

Sole Agent, May 2015

ad2-8

Media Morph, Inc.

Convertible Stock & Warrant

$8.0 million

Acted as Investment Agent, December 2012

M&A Transactions

ad2-9

ClinNet Solutions

Advised sale of company Sold to European Conglomerate

$18.0 million

ad2-10

Andover Medical Center

Roll-up of three specialty medical equipment companies

$50.0 million

ad2-11

STF Group Inc.

German producer of Thin Film panels

$23.0 million

International Deals

ad2-12

China Liandi

Convertible Preffered Stock & Warrant

$27.55 million

April 2010

ad2-13

Keyuan Petrochemicals

Convertible Preferred Series A Stock & Warrant Series A and B Comon Stock Series B Warant

$20.3 million

September 2010